Match each highly specific neurologic clinical vignette to the most appropriate initial or confirmatory diagnostic laboratory test.
- A 38-year-old woman presenting with severe, bilateral optic neuritis, sequential episodes of paraparesis, and intractable vomiting.Serum aquaporin-4 (AQP4) immunoglobulin G testing
- A 24-year-old woman with new-onset severe psychiatric symptoms, autonomic instability, orofacial dyskinesias, and an adnexal mass.Cerebrospinal fluid assay for anti-N-methyl-D-aspartate (NMDA) receptor antibodies
- A 55-year-old man with asymmetric, slowly progressive distal upper extremity weakness without sensory loss, and absent tendon reflexes in the affected limbs.Serum anti-GM1 ganglioside antibody testing
- A 35-year-old woman with a subacute onset of gait ataxia, ophthalmoplegia, and diffuse areflexia following a recent diarrheal illness.Serum anti-GQ1b ganglioside antibody testing
- A 65-year-old man exhibiting rapidly progressive cognitive decline over two months, accompanied by startle myoclonus and akinetic mutism.Cerebrospinal fluid real-time quaking-induced conversion (RT-QuIC) assay
Answer
Each distinct neurologic presentation matches a highly specific confirmatory laboratory test: NMOSD to AQP4 IgG, anti-NMDA receptor encephalitis to CSF NMDA receptor antibodies, multifocal motor neuropathy to anti-GM1 antibodies, Miller Fisher syndrome to anti-GQ1b antibodies, and Creutzfeldt-Jakob disease to the CSF RT-QuIC assay.
Correctly identifying these diseases requires recognizing highly specific clinical clues (e.g., an adnexal mass pointing to an ovarian teratoma in anti-NMDA receptor encephalitis, or intractable vomiting pointing to area postrema involvement in NMOSD) and knowing their paired autoantibodies or protein assays.
Step-by-Step Solution
Key Concept
Targeted laboratory evaluation for specific neuro-immunologic and prion diseases